A variant in a gene that promotes the production of testosterone by prostate cancer cells is linked to poorer survival and the development of castration-resistant disease in Caucasians with metastatic prostate cancer, a study suggests. Its researchers recommend that genetic testing be part of routine care for patients, as those with this variant may need more aggressive treatment. The study, “HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer,” was published in the journal…
April 25, 2020April 25, 2020